Skip to content
Search
Please enter at least 3 characters.

Latest Stories

Over 100 medicines are currently in short supply, warns BGMA

Over 100 medicines are currently in short supply, warns BGMA

Reducing disruptions to the movement of medicines around the world is “absolutely critical” for maintaining supply resilience in the UK, ABPI has suggested.  

The British Generic Manufacturers Association (BGMA) on Monday alerted the Health and Social Care Committee that medicines shortages have increased and are “around double what they were a year ago.”


BGMA chief executive Mark Samuels told the committee that they have been highlighting the medicine shortage risk to ministers since July 2021 and the association is “very concerned” about the current situation.

"We've been monitoring it for several years now, and as you saw in the written evidence, shortages have increased. They're around double what they were a year ago. We have them at 101 shortages in February this year,” said Samuels.

Dr Rick Greville, director of distribution and supply at the Association of the British Pharmaceutical Industry (ABPI), highlighted that the problem of drug shortages in the UK is a “long-standing issue" and the scarcity of certain medications "continues to be challenging".

Dr Leyla Hannbeck, CEO of the Association of Independent Multiple Pharmacies - AIMp, also raised concerns that community pharmacists in the UK are experiencing a “record number of medicines shortages,” and they spend long hours in the day trying to source medicines for patients.

She added that pharmacy teams see firsthand the anxiety and stress experienced by patients due to  medicine shortages.

Navin Khosla, Pharmacist at NowPatient, indicated that Brexit is mainly responsible for the drug shortage issue in the UK, citing reports from several news outlets.

Concerns were also raised about the potential harm of medication shortages in people with diabetes.

Last month, NHS England and the Department of Health and Social Care (DHSC) published a National Patient Safety Alert concerning the shortage of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), which are used to manage blood glucose levels in people with type 2 diabetes.

As per the alert, the supply of the drugs was not expected to return to normal “until at least the end of 2024”.

Helen Kirrane, head of policy, campaigns and mobilisation at Diabetes UK, informed the committee that the shortage of GLP-1 has significantly affected individuals with type 2 diabetes in the past six to eight months.

She expressed that the serious consequences often only become apparent over time, and there is  “serious concern about the harm that could be caused”.

Kirrane added that GLP-1 shortages have resulted in a “huge explosion of interest in this type of medication for weight loss globally over the last year or so” and the charity has seen a “huge surge” in off-label prescribing in the private sector.

To solve the drug shortage issue, Samuels suggested that staff at the Medicines and Healthcare products Regulatory Agency should be retained, as there is a “huge backlog” in the licensing of generic medicines.

Pharmacists should be empowered to make substitutions for alternative appropriate medication or formularies, suggested Janet Morrison, chief executive of Community Pharmacy England (CPE).

According to Dr Greville, reducing disruptions to the movement of medicines around the world is “absolutely critical” for maintaining supply resilience in the UK.

More For You

​The next generation of BD Rowa Smart launched

The latest BD Rowa™ Smart introduces a more intuitive user interface.

Photo credit: BD Rowa

BD Rowa unveils next-generation smart dispensing robot with sustainable design

Leading medical technology company BD Rowa has announced the launch of the next generation of its smart dispensing robot, offering enhanced convenience with a sustainable design.

Currently in its final development phase, the latest BD Rowa™ Smart introduces a more intuitive user interface designed to streamline operations and enhance the user experience.

Keep ReadingShow less
Independent Prescribing: Government aims to complete pathfinder programme evaluation by autumn 2025

Pharmacist prescribers at 210 ‘pathfinder’ sites were allowed to trial prescribing models within integrated primary care services.

Photo credit: gettyimages

Independent prescribing: Pathfinder programme evaluation to be completed by autumn, says Kinnock

Health minister Stephen Kinnock has revealed that the evaluation of the Community Pharmacy Independent Prescribing Pathfinder Programme could be completed by Autumn 2025.

Kinnock was responding to a question from James Naish, Labour MP for Rushcliffe, who asked what steps the minister was taking to ensure continued support for the Pathfinder Programme and independent prescribing to maximise direct prescribing capacity in England.

Keep ReadingShow less
NHS pharmacy funding not enough 2025: £3.073B deal with £1.99B gap fuels reform debate.

Funding alone isn’t going to be enough to save community pharmacy

Photo credit: gettyimages

New funding contract ‘not enough’ to release the sector from financial blackhole

After almost a year without an agreement, a new funding contract for community pharmacy was finally announced yesterday (31 March).

The settlement raises the baseline annual funding for the Community Pharmacy Contractual Framework (CPCF) in 2025/26 to £3.073 billion, with an additional £215 million secured to continue Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Free morning-after pill at pharmacies to end postcode lottery for patients

Pharmacy technicians will be allowed to supply of drospirenone for contraception under PGD,

gettyimages

Pharmacy contract: Free morning-after pill to be available at pharmacies soon

The UK government has announced that, for the first time ever, the ‘morning-after pill’ or emergency contraceptive pill will be available free of charge at pharmacies on the NHS, ending the postcode lottery women face in accessing the medicine and reducing inequalities.

The Department of Health and Social Care (DHSC) has confirmed a record £3.073 billion funding package for community pharmacies in 2025/26, alongside an additional £215 million to sustain Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Royal College status: The PDA calls for ‘meaningful and collaborative dialogue’

The profession’s success will depend on collaboration across all sectors, says PDA.

gettyimages

Royal College vote: Less than 7% of GB pharmacists in favour, says PDA

The Pharmacists’ Defence Association (PDA) has criticised the Royal Pharmaceutical Society (RPS) for moving too quickly to a ballot on its proposed transition to a Royal College, arguing that it resulted in low participation from pharmacists in Great Britain.

Announcing the results of the special resolution vote, the RPS said that the outcome was a “clear mandate” in favour of the transformative change.

Keep ReadingShow less